• Product number: C2109
  • CAS number: 503612-47-3
  • Molecular formula: C25H25N5O4
  • Molecular weight: 459,50 g.mol-1
  • Min. purity: 98,00 %
  • Synonyms: Apixabin
  • Solubility: refer to COA

  • Stability: ≥ 1 year
  • Shipping: 24/48h for products in stock
Make a request
Product Number: C2109


Apixaban is intended for Pharmaceuticals applications. Apixaban is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. All information about Apixaban is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.


  1. Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects? Blood Coagul Fibrinolysis. 2015 Dec; 26(8): 925–933. [...]
  2. A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies Journal of Chromatography B Volume 1144, 1 May 2020, 122095 [...]
  3. In vitro assessment of P-gp and BCRP transporter-mediated drug–drug interactions of riociguat with direct oral anticoagulants fundamental & clinical pharmacology, volume 34, issue 1, February 2020, p. 109-119 [...]
  4. Resolving DOAC interference on antithrombin activity testing on a FXa based method by the use of activated carbon. Clinica Chimica Acta - Volume 538, 1 January 2023, Pages 216-220 [...]